Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
302 JPY | +1.34% | +3.42% | +5.96% |
02-13 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
2023 | Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 | CI |
Business Summary
Number of employees: 46
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 100 | 100.0 % | 229 | 100.0 % | +128.85% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 100 | 100.0 % | 229 | 100.0 % | +128.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tomoyuki Asano
CHM | Chairman | 53 | 07-05-31 |
Koki Uehara
PSD | President | 46 | 07-07-31 |
Director/Board Member | - | - | |
Takahiro Kido
BRD | Director/Board Member | - | - |
Kiyoshi Nagata
BRD | Director/Board Member | 69 | 17-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kazumitsu Yabu
BRD | Director/Board Member | 65 | 15-03-31 |
Kiyoshi Nagata
BRD | Director/Board Member | 69 | 17-01-31 |
Masaya Onishi
BRD | Director/Board Member | 50 | 16-02-29 |
Tomoyuki Asano
CHM | Chairman | 53 | 07-05-31 |
Koki Uehara
PSD | President | 46 | 07-07-31 |
Yasuhira Tsujii
BRD | Director/Board Member | 45 | 18-05-31 |
Takahiro Kido
BRD | Director/Board Member | - | - |
Director/Board Member | - | - | |
Director/Board Member | 48 | - | |
Yuki Takei
BRD | Director/Board Member | 41 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 31,225,500 | 15,848,741 ( 50.76 %) | 59 ( 0.000189 %) | 50.76 % |
Company contact information
Stella Pharma Corp.
ORIX Koraibashi Building 3-2-7 Koraibashi
541-0043, Osaka
+
http://stella-pharma.co.jpSector
1st Jan change | Capi. | |
---|---|---|
+5.96% | 61.67M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- 4888 Stock
- Company Stella Pharma Corporation